Tech Company Financing Transactions
Veracyte Funding Round
Veracyte, based in San Francisco, secured $10.5 million in investment from Kleiner Perkins Caufield & Byers, TPG Capital and private investors.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
6000 Shoreline Ct. 300
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Veracyte (NASDAQ: VCYT) is pioneering the emerging field of molecular cytology. We are developing molecular tests designed to improve the diagnostic accuracy of cytology samples, thereby helping to increase the utility of these minimally invasive procedures as an alternative to surgical biopsy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bonnie Anderson
Chief Financial Officer
Giulia Kennedy
Chief Information Officer
Ashish Kheterpal
Chief Operating Officer
Christopher Hall
Chief Scientific Officer
Giulia Kennedy
VP - Bus. Development
John Hanna
Browse more venture capital transactions:
Prev: 9/30/2009: Agios Pharmaceuticals venture capital transaction
Next: 9/30/2009: Radar Networks venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs